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'L-6 is a multifunctional cytokine that regulates various .aspects of the immune response, acute-phase reaction, and hematopoiesis (1). Although not produced under normal circumstances, IL-6 is abnormally produced in a number of inflammatory, immune, and infectious diseases. However, because of the pleiotropic activity of the cytokine and the complex interplay of different cytokines with similar activities (2), the specific role of IL-6 in each pathological condition has not yet been defined. In human infection with HIV (3), but also in several experimental infections, high levels of IL-6 correlate with susceptibility to infection (4, 5) and severity of the associated disease (6) . Yet, IL-6 neutralization has been found to be protective in most (7, 8) but not all (9) of these experimental infections. One explanation may be the unexpected detection of high levels oflL-6 in anti-IL-6--treated mice, indicating the possible occurrence of "chaperoning" effects (7, 10) . For this reason, mice with a targeted mutation should provide a more useful means of evaluating the role of IL-6 in vivo.
Candida albicans is an opportunistic fungal pathogen commonly found in the gastrointestinal (GI) tract of humans (11) . Dissemination, which occurs under conditions lAbbreviations used in this paper: GI, gastrointestinal; NO, nitric oxide; PCA-2, live vaccine strain of C. albicans; I~T, reverse transcriptase. that compromise the host immune system (12) , results in a progressive disease associated with a high rate of mortality. In mice, the outcome of C. albicans infection is largely dependent upon the type of predominant Th cell subset (13, 14) . Thl cell responses associated with protection occur in genetically resistant mice after mouse vaccination with live vaccine strains of the yeast. Thl responses are also detected in susceptible mice after neutralization of IL-4 (15) or . These redirected responses lead to protection and onset of lasting anticandidal resistance. In contrast, unopposed Th2 cell responses are associated with susceptibility to infection and disease progression, as observed in genetically susceptible mice (17) and in resistant mice depleted of endogenous IFN-~ (18), IL-12 (19) , or TGF- [3 (20) .
In the course of candidal infections, IL-6 is rapidly detected in sera (21) and the cytokine is also produced by CD4 + Th2 cells upon antigen-specific stimulation in vitro (15) . In addition, overexpression of IL-6 in CAT/enhancer binding protein [3-deficient mice has recently been found to correlate with development of yeast-specific Th2-type responses (22) . Although pointing to a link between IL-6 production and disease outcome, these results do not clarify the functional role of IL-6 in candidal infections. In this study, IL-6-deficient mice generated by gene targeting (23) , were used to assess the role of IL-6 in resistance to Candida. IL-6-deficient (IL-6-/-) mice were found to be highly susceptible to both systemic and GI infections. This susceptibility correlated with defective neutrophil function and the development of a T cell reactivity biased towards the Th2 pathway.
Materials and Methods
Mice. IL-6-/-and +/+ female nfice were bred in our barrier facility, and were used by the age of 8-10 wk. The generation and genetic background of these mice have been described in detail (23 Yeasts, Infections, In Vivo Analysis and Treatments. The origin and characteristics of the C. albicans highly virulent CA-6 strain and the live vaccine strain PCA-2 used in this study have already been described in detail (17) . For infection, cells were washed twice in saline, and diluted to the desired density to be injected intravenously or intragastrically into mice. Quantification of yeast cells in organs of infected mice (four to six per group) was performed by a plate dilution method, using Sabouraud dextrose agar, and results (means -+ SEM) were expressed as CFU per organ. For histology, tissues were excised and immediately fixed in formalin. Sections (3-4 p~m) of paraffin-embedded tissues were stained with periodic acid-Schiff reagent and examined for histology, as described (25) . Mice succumbing to yeast challenge were routinely necropsied for histopathological confirmation of disseminated candidiasis. For differential blood counts, animals were bled through the tail vein and smears were stained with May-Griinwald Giemsa reagents (Sigma Chemical Co., St. Louis, MO) before analysis. Recombinant human IL-6 was produced in Escherichia coli and purified to homogeneity according to published procedures, with minor modifications (26) . Protein concentration was determined by analysis of the purified product. The specific bioactivity was 2 • 10 s U/rag of protein as assessed by the 7TD1 cell growth assay (27) . The recombinant IL-6 (10 /~g) was given in 0.2 ml s.c. ofPBS 4 h before and 1 d after challenge. Control mace received vehicle alone. IL-10-neutralizing antibodies (100 ~zg of affinitypurified mAb from SXC-1 hybridoma; American Type Culture Collection, Rockville, MD) was injected into mice 1 d before challenge. Depletion of neutrophils was performed by injecting the mice 4 h before infection with 30 p.g i.p. of the affinity-purified RB6-8C5 rat IgG2b antibody, a gift from Dr. IL.L. Coffman (DNAX Research Institute, Palo Alto, CA). An equivalent amount of isotype-matched antibodies (Zymed Laboratories, Inc., South San Francisco, CA) was injected into control mice. Endotoxin was removed from all solutions with Detoxi-gel (Pierce Chemical Co., Rockford, IL).
Macrophage Cultures and Nitrite Determination. Macrophages were obtained from spleen cell suspensions and nitrite concentration, a measure of nitric oxide (NO) synthesis, was determined as described (28) . Briefly, plastic adherent spleen cells were incubated overnight in the presence of 100 U/m] of rlFN-~/ and 10 ng/ml of LPS (Sigma Chemical Co.). Viable yeast cells were then added, and supernatants were removed after 4 h and assessed for nitrite content.
Antibody Assay. A micro-ELISA procedure was employed to quantitate total and yeast-specific antibodies in sera (IgG2a and lgE) and fecal samples (IgA) of mice (17, 25) .
Cell Cultures. Unfractionated splenocytes (5 • 106/ml) were cultured in the presence of 5 • 105 heat-inactivated Candida cells, in RPMI 1640 medium, 10% FCS, and antibiotics. CD4 + lymphocytes were positively selected from pools of spleen cells by means of a panning procedure using purified antimurine CD4 mAb GK1.5, which resulted in a >95% pure population via FACS | analysis. CD4 + (5 • 106) cells were cultured in the presence of 5 • 10 s irradiated (2,000 rad) splenocytes and heat-inactivated yeast cells. Cytokine measurements were performed in supernatants collected after 48 h, as described (17) .
Enumeration of Cytokine-producing CD4 § Cells and Cytokine Assays. The procedure used to enumerate cytokine-producing cells was based on a spot ELISA, using CD4 § cells from freshly isolated splenocytes, as described previously (16, 25) . Source and characteristics of the antibody reagents used in IFN-y, IL-2, IL-4, and IL-10 ELISPOT and ELISA assays were as described (16, 19, 29) . In IL-6 measurement, two-site ELISA involved the use of mAb MP5-20F3 in combination with biotinylated monoclonal MP5-32cll (PharMingen, San Diego, CA). In the ELISPOT assays, spots were counted with the aid of a dissecting microscope, and results were expressed as the mean number of cytokine-producing cells per 104 cells, calculated using replicates of serial twofold dilutions of cells pooled from four mice per group. Cytokine titers were calculated by reference to standard curves constructed with known amounts of the recombinant cytokines.
RNA Preparation and Reverse Transcriptase. CD4 + lymphocytes (2 • 107 cells) or adherent macrophages from pooled spleens of three to four animals were subjected to RNA extraction by the guanidium thiocyanate-phenol-chloroform procedure, as described (30) . Briefly, 3 Izg of total RNA was incubated with 0.5 p,g of oligo(dT) (Pharmacia, Uppsala, Sweden) for 3 rain at 65~ and chilled on ice for 5 rain. Each sample was then incubated for 2 h at 42~ after adding 20 U RNase inhibitors (Boehringer Mannheim, Milan, Italy), 1.5 mM deoxynucleoside triphosphates, 25 U avian myeloblastosis virus reverse transcriptase (RT; Boehringer Mannheim), and RT buffer (50 mM Tris-HC1, pH 8.3, 8 mM MgC12, 30 mM KCI, and 10 m/Vl dithiothreitol, final concentration) in a final volume of 20 ~1. cDNA was diluted to a total volume of 500 ILl with TE buffer (10 mM Tris-HC1, 1 mM EDTA, pH 8.0) and frozen at -20~ until use. Amplification of synthesized cDNA from each sample was carried out as described previously (31) . Briefly, 5 I*1 of cDNA was added to a reaction mixture containing 50 mlVl KC1, 10 mM Tris-HC1, pH 8.3, 3.0 mM MgC1 z, 0.01% gelatin, 0.2 deoxynucleoside triphosphate, 1 I~M of each primer, and 2.5 U AmpliTaq polymerase (PerkinElmer Corp., Hayward, CA). Each 100-1xl sample was overlaid with 75 p~l mineral oil (Sigma Chemical Co.) and incubated in a DNA Thermal Cycler 480 (Perk.in-Elmer Corp.) for a total of 30 cycles for each cytokine. For [3-actin-specific primers, each cycle consisted of 1 rain at 94~ 1 man at 60~ and I man at 72~ for IL-4, 1 rain at 94~ 1 n-fin at 67~ and 1 rain at 72~ for IL-10, 10 s at 91~ 25 s at 59~ and 25 s at 72~ and for IL-12p40, I rain at 94~ 1 rain at 67~ and 1 rain at 72~ IL-4, IL-10, and IL12p40 primers and the positive controls were as described elsewhere (15, 16, 19, 29) . The [3-actin primers were used as a control for both RT and the PCR reaction itself, and also for comparing the amount of products from samples obtained with the same primer. The PCR fragments were analyzed by 1.5% agarose gel electrophoresis and visualized by ethidium bromide staining. PCP,-assisted mRNA amplification was repeated at least twice for at least two separately prepared cDNA samples for each experiment. Data are representative of at least three different experiments.
Statistical Analysis. Statistical analysis was done using the Student's t test; P <0.05 was considered significant.
Results

IL-6-/-Are More Susceptible than IL-6+ /+ Mice to C. albicans Infections.
To evaluate the susceptibility of IL-6-/-and IL-6+/+ mice to C. albicans infection, mice were injected intravenously with different doses (10 6 or 10 5 ) either of highly virulent CA-6 yeast cells or of the live vaccine strain PCA-2. Groups of mice were instead infected intragastrically with 108 CA-6 cells. The animals were monitored for mortality, fungal load in the organs, and resistance to secondary challenge. Although the median survival times of mice injected intravenously with the higher CA-6 inoculum did not differ between the two types of infected host, IL-6-deficient mice succumbed to infection with 105 cells, in contrast to the long-term survival of IL-6+/+ mice (Table 1) . However, both IL-6+/+ and -/-mice resisted challenge with 104 CA-6 cells (data not shown). IL-6-/-mice were also more susceptible to the higher (10 6 cells) inocnlum of PCA-2, with a greater than 65% death rate within 3 wk of infection. With the lower (105 cells) inoculum, both types of mice survived primary challenge; however, they exhibited disparate susceptibilities to rechallenge with virulent CA-6, in that only the IL-6+/+ mice resisted the secondary infection ( Table 1) .
As the genetic background has been found to contribute to the resistance of an IL-4-deficient 129 mouse strain to murine acquired immunodeficiency syndrome (MAIDS) in- fection (32), we assessed the relative susceptibility to CA-6 infection of 129/SV/EV mice (24), the strain from which the embryonic stem cells (CCE) used for homologous recombination had been derived (23) . The results (see note to Table 1) showed these mice to be as resistant to infection as the IL-6+/+ mice, thus ruling out that genetic background, rather than IL-6 defciency, might be primarily responsible for the susceptibility of IL-6-/-mice to C. albicans infection. Quantification of yeast cells recovered from the systemically infected mice revealed the presence of higher numbers of C. albicans viable units in the kidneys, livers and, in particular, brains, of IL-6-/-mice (Fig. 1 A) .
Based on the finding that IL-6 promotes IgA secretion by Peyer's patches (33) and that IL-6-/-mice fail to develop strong mucosal antibody responses to viral infection (34), we examined the course ofGI candidiasis in IL-6-/-and IL-6+/+ mice. Course and outcome of GI infection are influenced by the host mucosal immune status (25) . No differences in survival could be found after intragastric challenge (Table 1) . However, analogous to what was found in the systemic infection, the number of yeast cells recovered from the stomachs of IL-6-/-mice was higher than that observed in IL-6+/+ mice, at all time points examined ( Fig. 1 B) , even though both types of host would eventually clear their mucosal infections. It is interesting to note that extensive fungal growth was detected in the esophagus of IL-6-/-mice, an occurrence typical of severely immunodeficient animals (35) . Also, increased yeast dissemination occurred to the kidneys in IL-6-/-mice.
Histological examination of the kidneys from mice infected intravenously with CA-6 cells (Fig. 2, A and B) revealed the presence ofmicroabscesses with abundant neutrophil infiltration within tubules, particularly in IL-6-/-mice. In addition, lesions tended to be larger, showed considerable necrosis, and contained hyphal aggregates and yeast cells in IL-6-/-mice, whereas signs of progressive resolution with no visible yeasts were observed in the wild-type controls. Of interest, inflammatory lesions in the kidney cortex were almost exclusively found in the IL-6+/+ mice (Fig.  2, A and B) , raising the possibility that IL-6 might have an ambivalent role in the pathogenesis of renal candidiasis, as it is required for development of cortex lesions.
In the GI infection (Fig. 2, C and D) , sections of the stomachs from either type of mice revealed the presence of abscesses in the region of the cardiac-atrial fold, the principal site of gastric infection in mice (36) . Abscesses, characterized by yeast cells surrounded by a keratinized upper layer and a basal epithelium layer, were more numerous in IL-6-/-than +/+ mice. Also, extensive mononuclear cell and neutrophil responses were evident in the submucosa and the lamina propria of only IL-6-/-mice.
All together, these results indicated that IL-6 deficiency in mice is associated with increased susceptibility and more severe pathology caused by systemic and mucosal C. albicans infections. (') No viable yeast units found.
Susceptibility of lL-6-/-Mice to Candidiasis Is
protective forms of specific immunity to C. albicans correlate in mice with the respective expansion of Thl and Th2 cells (13) , parameters of CD4 + Th cell immunity were examined in IL-6-/-and control mice with systemic or GI candidiasis. Ig levels as well as patterns ofThl/Th2 cytokine production were evaluated in mice injected intravenously with CA-6 or PCA-2 ceils, or infected intragastrically with CA-6 cells. In uninfected mice, no differences were found in the production of IgG2a or IgE, although a significant decrease in total IgA fecal content was present in IL-6-/-mice (Fig. 3) . However, after i.v. infection with PCA-2,
Candida-specific IgE levels were higher in IL-6+/+ mice, whereas in contrast, specific IgG2a levels were higher in IL-6-/-mice. In GI-infected mice, the Candida-specific
IgA content was significandy lower in fecal samples from IL-6-/-mice (Fig. 3) .
For studying cytokine production, we assessed cytokine levels in sera and frequencies of cytokine-producing cells in spleens, together with the qualitative pattern ofcytokine gene expression. Because circulating levels of IL-12, rather than IFN-',/, correlate with Thl development in candidiasis (29), we quantitated the presence ofbioactive IL-12 in the sera of IL-6-/-and control mice infected with PCA-2. We found (Fig. 3 ) these levels to be higher in resistant IL-6+/+ than in susceptible IL-6-/-mice, although IL-12 could be detected in both cases. In contrast, IL-12 levels were below the detection limits of the assay in both types of uninfected host. Fig. 3 also shows that, whereas serum levels of IL-4 did not apparently increase in response to infection in either type of mice, the levels of circulating IL-10, although increased in both types of mice, were higher in IL-6-/-mice with systemic or GI infection.
Depending on the yeast/host combination and outcome of infection, IL-4 (15, 37), IL-10 (16), and IL-12 (19, 29) are key contributors to the cytokine balance affecting Th cell differentiation. Therefore, we evaluated the simultaneous expression of these cytokines in the spleens of IL-6-/-and control mice injected intravenously with CA-6 or PCA-2 cells. 6 d after infection, spleens were harvested and message levels of IL-4, IL-10, and IL-12p40 were assayed in purified CD4 + cells or macrophages by RT-PCR analysis. The results (Fig. 4) showed that the IL-4--specific message was not (PCA-2) or barely (CA-6) detectable in CD4 + cells from Candida-infected IL-6-/-mice but was clearly expressed by IL-6+/+ and 129 mice. In contrast, IL-10 messages were present in IL-6-/-and +/+ mice, as well as in 129 mice. Moreover, the IL-12p40 message was present in all types of mice injected with PCA-2 but not with CA-6.
To correlate these findings with cytokine production by CD4 + cells from infected mice, the frequencies of CD4 + cells producing IFN-y, IL-2, IL-4, and IL-10 cytokines were determined in IL-6-/-and +/+ mice after primary PCA-2 infection or after reinfection at 2 wk with CA-6 cells. At 3 d after primary or secondary infection, the number of IFN-~/-, IL-2-, IL-4--, and IL-10-producing CD4 + cells (freshly isolated from the spleens of infected mice) was determined by means of an ELISPOT assay (Fig. 5) . A fourfold increase in the number of IL-10-producing cells and an almost twofold increase for those producing IL-4 were found in the spleens of IL-6-/-mice after PCA-2 infection as compared to uninfected mice. In contrast, the frequencies of cytokine-producing cells in infected IL-6 +/+ mice were not significantly different from those in unin- (29), we assessed such productions together with the pattern of resistance in I L -6 -/ -and control mice after intravenous challenge with PCA-2 in the presence of IL-10--neutralizing mAb (Table 2) . IL-10 neutralization did not affect resistance in IL-6 + / + mice, yet significantly increased survival in I L -6 -/ -mice. The protective effect ofanti-IL-10 was associated with elevated serum levels ofbioactive IL-12 and upregulation of N O release by activated macrophages; both functions were defective in I L -6 -/ -nfice, infected (Table  2) or not (data not shown) with PCA-2. Therefore, overproduction of IL-10 seemed to play an important role in the susceptibility to Candida infection and the development of nonhealing Th2 cell responses in I L -6 -/ -mice. However, the T cell response could be redirected to a T h l pattern of reactivity by anti-IL-10 treatment.
Susceptibility and Resistance to Candidiasis Correlate with the Levels of Endogenous IL-6 in Conventional Mice.
To further define the role of IL-6 in candidiasis, we measured IL-6 production in previously established models of healing or nonhealing infections in which the patterns of Th cell responses have been best characterized (19) . Accordingly, IL-6 levels were measured in culture supernatants of splenocytes from CD2Fi mice, injected intravenously 2 d earlier with escalating doses of either CA-6 (nonhealing infection) or PCA-2 (healing infection) after restimulation in vitro with Candida antigens (Fig. 6) . In both infections, the produc- tion of IL-6 directly correlated with the fungal dose used for the in vivo challenge, being the highest in mice given the largest inoculum of the yeast. A similar dependence of IL-6 production on size of microbial challenge has been observed in Listeria (38) and HIV (39) infections. In our experiments with CD2F 1 mice challenged with high-or low-virulence Candida, the highest production of IL-6 was detected in nonhealer mice (Fig. 6 ) and relatively high levels of IL-6 were also found in early sera from these animals (data not shown), analogous to the results of others in another system (21) . However, in experiments not reported Table 2 .
IL-10 Neutralization Increases Th 1-mediated Resistance in IL-6-/-Mice with Systemic Candidiasis
Anti *Anti-IL10--neutralizing mAb (100 p.g/mouse) was given intraperitoneally 4 h before challenge. Control mice received an equal amount of isotype-matched purified antibodies. ~Adherent macrophages from 3-d-infected mice were cultured overnight with IFN-~/ (100 U/ml) and LPS (10 ng/rul) before determination of nitrite content (Ixm/107 cells). IIIL-12p70 (ng/ml) was determined in sera pooled from three to five mice at 6 d of infection. 82 <0.05 (anti-IL-10-treated versus controls).
here, we found that administration of IL-6 to healer mice (with an apparently low endogenous production of the cytokine) decreased fungal load, which would instead be increased by IL-6 neutralization in nonhealer mice. Therefore, the early production of IL-6 may represent an important defense mechanism to limit candidal infection. Because IL-6 does not affect the growth of Candida in vitro (our unpublished observations), it is likely that the effects of IL-6 in vivo occur via activation of antifungal effector functions, such as those typically mediated by phagocytic cells. (xl03 CA-6) (xlO 6 PCA-2)
Number of C. albicans cells 
Exogenous IL-6 Restores Neutrophil Effector Function and Increases Resistance in IL-6-deficient Mice. One such effector
function is mediated by neutrophils, such that their ablation in vivo increases susceptibility to candidal infection and promotes Th2 development (13) . Significandy, 1L-6--deficient mice are unable to mount peripheral blood neutrophilia in response to Listeria infection (40) . Therefore, it seemed of interest to measure the number of peripheral blood neutrophils in IL-6-/-and +/+ mice before and after C. albicans infection. Neutrophil counts did not significantly differ in uninfected IL-6-deficient and control mice (Table 3 , groups 1 and 6); however, at 2 d after infection, the number of peripheral blood neutrophils failed to increase in IL-6-/-mice in contrast to what observed in IL-6 + / + mice (groups 2 and 7).
To define the role of neutrophils as antifungal effectors in IL-6-/-and +/+ mice, both types of mice were depleted ofneutrophils by treatment with grannlocyte-depleting mAb, according to a procedure estabhshed previously in yeast-infected CD2F1 mice (13) . Neutrophil depletion, at the time of C. albicans challenge, dramatically increased susceptibility to infection in both types of mice, as shown by the occurrence of median survival times of 2 d (Table 3 , groups 3 and 8). However, recombinant human IL-6 administered to yeast-infected IL-6-/-mice (group 4), resulted in a dramatic increase in the number of peripheral blood neutrophils, provided that the animals had not been treated with the mAb (group 5). Concomitantly, there was a twofold decrease in the number of yeast cells recovered from the kidneys (groups 2 and 4). The number of yeast units in the kidneys was also lower at 7 d of infection (fourfold decrease, data not shown). It is interesting to note that no such effect was observed in neutrophil-depleted mice.
Indeed, similar to the effect of IL-10 neutralization (Table  2) , the administration ofrlL-6 to the yeast-infected IL-6-/-mice significantly increased their survival times, from 14 to >60 d (groups 2 and 4, respectively, Table 3 ).
Discussion
This study demonstrates that IL-6 deficiency, resulting from gene targeting, increases mouse susceptibility to C. albicans infection and prevents development of protective Thl-mediated immunity. This effect is reversed by neutralization of endogenous IL-10 or administration of rlL-6, suggesting that production oflL-6 may represent an important defense mechanism against candidal infection. However, the limited IL-6 production found in conventional mice with healing infection of the yeast would suggest that the production of IL-6 must be stricdy regulated, in accordance with the notion that immunopathological consequences may result from its deregulation (41) . This is also consistent with previous findings of a deleterious effect of IL-6 overexpression in C/EBPI3 mice infected with Candida (22) . The increase in fungal load found not only in the kidneys and livers, but also in the brains of systemically infected IL-6-deficient mice may indicate a possible unique role for IL-6 in immunosurveiUance in this compartment (42) . However, another observation in this study was that highly susceptible IL-6-deficient mice did not develop as severe renal pathology in the cortex as the otherwise resistant IL-6+/+ mice. Because of the known involvement of IL-6 in mesangial prohferative disorders (43) , it is possible that this cytokine plays a deleterious role in renal disease by
Candida.
The interplay between the innate and acquired immune system is considered to be fundamental in the general defense against infections (44) , and IL-6, through either endocrine, paracrine, or autocrine pathways of activation, appears to be important to the successful development of both forms of immunity. However, IL-6 may be more critical in the promotion of cellular immunity (45) than in short-term events, such as shock (46) and LPS-induced systemic inflammation (47) . IL-6 acts as a potent costimulatory signal in CD4 + T cell activation and promotes both cytotoxic T cell differentiation and NK function (41) . A deficient IL-6 production is known to impair T cell activation and to increase susceptibility to Listeria infection (45) . IL-6 is also required for the induction of T cell-mediated resistance to Mycobacterium avium (48) .
We have observed that IL-6-/-mice default to the Th2 pathway in response to a low-virulence C. albicans strain that, in contrast, induces a preponderance of Thl responses in IL-6+/+ mice. IL-10, rather than IL-4, was the main cytokine produced by the IL-6-/-former mice in response to primary infection. This could explain the pattern of Ig production observed in sera as well as the low levels of bioactive IL-12p70 produced by the IL-6-deficient mice. IL-10 induces the synthesis of IgG with no direct effect on IgE production (49) and strongly inhibits IL-12 production (50). However, the number oflL-4-producing CD4 + cells was greatly increased by yeast reinfection, which indicates that memory CD4 + T cells will produce substantial amounts of IL-4 upon secondary challenge. The finding of a relatively low production of IL-4 in IL-6+/+ and 129 mice challenged with virulent Candida suggests that genetically determined factors in addition to IL-4 could mediate susceptibility to infection in these mice, a possibility that may be at work in MAIDS infection as well (32) . The genetic T cell background is likewise important in determining default Th phenotype development in an in vitro system (51) .
Whether IL-6 has a direct effect on the developing CD4 + T cells in candidiasis is unclear. We do not favor the hypothesis of a direct role, also considering the recent finding that the protective effect of rlL-6 in murine listeriosis is independent of lymphocytes (40) . The low levels of IL-12 produced by IL-6-deficient mice may well explain their failure to mount a sufficient Thl response. As a matter of fact, the finding of upregulated IL-12 production and increased resistance to infection after IL-10 neutralization suggests that an appropriate immune response will take place in IL-6-/-mice when the effects of the opposing cytokine, IL-10, are neutralized.
That IL-10 may prevent development of protective Thl responses in mice with candidiasis has already been shown (52) . In addition, in genetically susceptible DBA/2 mice, the emergence of protective Thl reactivity after IL-10 neutralization is concomitant with upregulation of NO release by splenic macrophages (16) . We have assessed NO production by macrophages from IL-6-/-and +/+ mice infected with C. albicans. Although NO release by elicited peritoneal (45) or splenic macrophages in Listeria infection (40) is not different in independently derived IL-6-/-and control mice, we did observe defective NO production by activated splenic macrophages from C. albicansinfected IL-6-deficient mice. Because IL-10 neutralization was followed by upregulation of NO production, it is likely that IL-10 was primarily responsible for the impaired NO release observed in IL-6-/-mice. Whether the (relative) overproduction of IL-10 is directly related to IL-6 deficiency remains to be clarified.
It is interesting to note that increased production oflL-10 is a common finding in C. albicans-infected neutropenic mice (P, omani L., A. Meucacci, E. Cenci, P,.. Spaccapelo, P. Puccetti, and F. Bistoni, manuscript in preparation). After neutrophil depletion, otherwise resistant mice exhibit high susceptibility to infection associated with Th2, rather than Thl responses. Neutrophils may actively participate in the selection of the Th response by modifying the cytokine milieu at the time of infection, this being individually the most critical factor in Th cell differentiation to Candida (13) . We found that the number of neutrophils was lower in IL-6-/-than in IL-6+/+ mice, and, in particular, that IL-6-/-mice were unable to mount peripheral blood neutrophilia in response to infection. A similar condition has recently been observed in IL-6-deficient mice in response to Listeria infection (40) . However, an anticandidal effect was found to result from administration of exogenous IL-6; this correlated with increased counts of circulating neutrophils. The therapeutic activity of IL-6 was lost in neutrophil-depleted mice, which suggests a neutrophil dependence of the effect. These findings are in line with the IL-6--promoting activity on granulocyte and macrophage colony development from murine progenitor cells (53) and with the significant increase in neutrophils observed after IL-6 injection (54) . These data also suggest that IL-6 participates in the early defense to C. albicans infection by stimulating neutrophils, either directly or indirectly. IL-6 is known to influence the oxidative burst and destructive capacity of human neutrophils (55) , raising the possibility that the neutrophil effector function may be impaired in IL-6-deficient mice as well.
All together, these results indicate that a defective innate immune response, such as an inefficient neutrophil function, together with the negative effect of unopposed cytokines, such as IL-10, on macrophage activity, may contribute to the inability of IL-6-deficient mice to mount protective Thl responses in candidiasis. In GI infection, a further negative effect could result from impaired IgA secretion, even though the precise role of IgA in mucosal candidiasis is still to be defined (25) .
Thl development in candidiasis appears to require a critical balance of cytokines acting directly or indirectly on CD4 + subset differentiation. In addition to previous evidence for an obligatory role oflFN-y (18), IL-12 (19) , and TGF- [3 (20) , the present data establish IL-6 as another cytokine that, presumably via effects on innate response mechanisms, permits optimal development of Thl reactivity leading to lasting anticandidal protection.
